Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the […]
FDA grants Medtronic an IDE to study new tech for ablating heart tissue
Medtronic (NYSE:MDT) announced today that it won FDA approval to move forward with an investigational device exemption trial to evaluate the safety and effectiveness of its PulseSelect pulsed-field ablation (PFA) system. The PulseSelect system is designed to use the pulsed electric fields to treat atrial fibrillation (Afib). It uses the fields to ablate or create lesions […]
Medtronic touts 3-month clinical trial results using Stimgenics spinal cord stimulation
Medtronic (NYSE:MDT) this week touted results from a three-month clinical trial of the recently acquired Stimgenics Differential Target Multiplexed Spinal Cord Stimulation using Medtronic’s Intellis platform. The large, multicenter randomized controlled trial showed that 80% of patients with chronic back pain that were treated with Differential Target Multiplexed (DTM) reported at least 50% pain relief […]
Medtronic launches data management software program for Synchromed II
Medtronic (NYSE:MDT) this week launched a cloud-based data management software platform for its Synchromed II drug delivery system. The Efficio platform is designed to allow clinicians to manage targeted drug delivery pump practices to treat patients who have chronic pain, cancer pain and severe spasticity. It consolidates, organizes and provides visual summaries of patient data received […]
Outgoing Medtronic CEO Ishrak to chair Intel’s board
Omar Ishrak — slated to step down as CEO of Medtronic (NYSE:MDT) in April — is now the independent chair of the board at tech giant (NSDQ:INTC). Ishrak replaces Andy Bryant, who plans to retire from Intel’s board in May. “I have full confidence in Omar leading the board, which is fortunate to have his expertise […]
BREAKING: Medtronic wins FDA approval for Micra AV
Medtronic (NYSE:MDT) has won FDA approval for its Micra AV — greatly expanding the number of people who could potentially benefit from leadless pacemaker technology. The medical device giant plans to start offering the Micra AV in a limited number of implanting centers in the coming weeks, with a full launch expected in the spring. FDA […]
Phoenix Children’s Hospital to deploy Medtronic neurosurgery robot
Phoenix Children’s Hospital will be the first health system in the U.S. to deploy the newly FDA-cleared Medtronic Stealth Autoguide platform to perform robotic neurosurgery on pediatric patients. The Barrow Neurological Institute (BNI) at Phoenix Children’s will use Stealth Autoguide with Medtronic’s StealthStation system. The hospital expects procedures to start later this month, according to […]
Medtronic issues urgent field safety notice for O-arm imaging system
Medtronic (NYSE:MDT) announced that it determined that a replacement of the internal gantry tractor motor drive will resolve an issue with the O-arm O2 imaging system that the company warned customers of last year. In November, Medtronic notified customers of the potential for navigational inaccuracy with the O-arm O2 system’s auto-registration feature when used in conjunction […]
Medtronic wins 2020 Catalyst Award
Medtronic (NYSE:MDT) announced today that it was one of three recipients of the 2020 Catalyst Award in recognition of the its initiatives for fostering a workplace in which women can advance. The medtech giant said it is being recognized by Catalyst, a nonprofit seeking to build “workplaces that work for women,” for its Medtronic Women’s Network […]
Medtronic wins CE Mark for next-gen InterStim products
Medtronic (NYSE:MDT) announced today that it received CE Mark approval for its InterStim Micro neurostimulator and InterStim SureScan MRI leads. The medtech giant plans to make the products available on the market on Jan. 15 to expand access to sacral neuromodulation (SNM) therapy for European patients, according to a news release. InterStim Micro is a rechargeable […]
7 medtech advances to improve diabetes treatment
Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple treatments and technologies have cleared regulatory hurdles and are now hitting the market and making the process of living with diabetes that much more manageable. Several different styles of therapy and devices have come […]
- 1
- 2
- 3
- …
- 85
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube